2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Friday, February 12, 2016
Text Size
   

BSK CONFERENCE

BIOETHICS SOCIETY OF KENYA'S INAUGURAL CONFERENCE

16th - 17th DECEMBER, 2015

bsk conference

downloadsubscribe


6th KASH CONFERENCE

ASTMH

9th FEBRUARY, 2016


The Kenya Medical Research Institute is pleased to host the first ever American Society for Tropical Medicine and Hygiene (ASTMH) event in Africa just preceeding the 6th KASH Conference on the 9th Feb 2016.

6TH KASH CONFERENCE

10th & 12th FEBRUARY, 2016


Poster 


 

downloadsubscribe

Job Opportunities

Vacancies KEMRI

Invitation To Tender

 INVITATION TO TENDER

   Click Here



Calendar of Events

February 2016 March 2016
Su Mo Tu We Th Fr Sa
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29
There are no upcoming events to display
View Full Calendar

Newsletters

biotechnologynewsletteroct

 

KEMRI Bioethics Revew Issue 4 2015

 

kemri bulletin issue 4

downloadsubscribe


 

 

 

 

 

 

      

KEMRI destroys its stockpiles of Polio viruses

Polio Destruction

Acting Director KEMRI, Dr. Gerald Mkoji addressing the press flunked on his right by the Head of Disease Surveillance and Response Dr. Daniel Langat and the WHO Coordinator of Polio Eradication for the Horn of Africa, Dr. Sam Okiror shortly before destroying the polio subtype 2 virus at the Institute yesterday.

Read More

Switzerland seeks more collaboration with KEMRI Scientists

Swiss

Ambassador, Mauro Moruzzi, the head of International Affairs at the Swiss State Secretariat for Education, Research and Innovation is briefed by the Acting Director, KEMRI, Dr. Gerald Mkoji. Amb. Moruzzi lead a delegation of 15 researchers and academicians in a tour of the Institute on Thursday, 14th, January, 2016.


Read More

KENYA MEDICAL RESEARCH INSTITUTE (KEMRI)
2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.

 

Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI

 

US Defense Threat Reduction Agency (DTRA) Director visits KEMRI

 

 

DTRA

The Director of the United States Department of Defense, Defense Threat Reduction Agency (DTRA),Dr. Elizabeth S. George,(seated,fourth from right) poses for a group photograph with KEMRI staff led by Deputy Director in charge of Research & Development ,Prof. Elizabeth Bukusi (seated, fourth from left) when she visited KEMRI on Monday, 25th, January, 2016.

DTRA director who was accompanied by other officials from the agency pledged to continue supporting the Institute to improve its levels of preparedness and reduction of any threat emanating from its work.

Headquartered in Fort Belvoir, Virginia in the US, DTRA's main functions are threat reduction, threat control, combat support, and technology development. Prof. Bukusi represented, Acting Director, KEMRI, Dr. Gerald Mkoji at the function.

We have 395 guests online

Vision

"To be a leading centre of excellence in research for human health."

Mission

"To improve human health and quality of life through research, capacity building, innovation and service delivery."

                                                                                                                                                                                                                                           iso90012008

                                                                                                                                             

Motto

"In Search of Better Health"
towards the realization of our Vision

 

 

KEMRI ISO 9001:2008 CERTIFIED

Complaints

Do you have a complaint?
Click Here